Showing results (91-100 of 136) with videos related to
Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|May 11, 2001
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micellesL van Zuylen, M O Karlsson, J Verweij, et al.International Journal of Cancer|May 4, 1999
Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell linesH Burger, K Nooter, A W Boersma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumorsA Sparreboom, M J de Jonge, C J Punt, et al.Cancer Biology & Therapy|May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecanAlex Sparreboom, Walter J Loos, Herman Burger, et al.Anti-Cancer Drugs|March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysisWalter J Loos, Hans Gelderblom, Jaap Verweij, et al.Blood|November 15, 1993
Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cellsP A te Boekhorst, K de Leeuw, M Schoester, et al.British Journal of Cancer|July 4, 1998
Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell lineJ Ma, M Maliepaard, K Nooter, et al.The Medical Journal of Malaysia|November 26, 2008
Selectivity of compounds isolated from the leaves of Nerium indicum Mill. on various human cancer cell linesS H W Mae, M Sofia, R L H Bolhuis, et al.Cancer Research|October 5, 2001
SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell lineP W Schenk, A W Boersma, J A Brandsma, et al.Analytical Biochemistry|February 6, 1998
Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassayA Sparreboom, W J Loos, J Verweij, et al.Pageof 14